1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Age-Related Eye Disease Study (AREDS) News Conference\n"}],["$","meta","1",{"name":"description","content":"AMD and cataract are the leading causes of visual impairment and blindness in the United States. Based on many clinical studies, it is apparent that the frequency of both diseases increases dramatically after age 60. Although excellent treatments for cataract are available, there are no equivalent treatments for AMD. As the average lifespan of our population increases, the number of people who develop AMD will increase dramatically in the years ahead. Unless successful means of prevention or treatment are developed, blindness from AMD -- and its importance as a public health problem -- will increase.\n\n

\n\n\nFor more information, visit
\nAge-Related Eye Disease Study
\n\n\n\n"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Age-Related Eye Disease Study (AREDS) News Conference\n"}],["$","meta","4",{"property":"og:description","content":"AMD and cataract are the leading causes of visual impairment and blindness in the United States. Based on many clinical studies, it is apparent that the frequency of both diseases increases dramatically after age 60. Although excellent treatments for cataract are available, there are no equivalent treatments for AMD. As the average lifespan of our population increases, the number of people who develop AMD will increase dramatically in the years ahead. Unless successful means of prevention or treatment are developed, blindness from AMD -- and its importance as a public health problem -- will increase.\n\n

\n\n\nFor more information, visit
\nAge-Related Eye Disease Study
\n\n\n\n"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/96e214d8-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/c30a5cac-2566-4726-bf2f-ef2e635696a1.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Age-Related Eye Disease Study (AREDS) News Conference\n"}],["$","meta","11",{"name":"twitter:description","content":"AMD and cataract are the leading causes of visual impairment and blindness in the United States. Based on many clinical studies, it is apparent that the frequency of both diseases increases dramatically after age 60. Although excellent treatments for cataract are available, there are no equivalent treatments for AMD. As the average lifespan of our population increases, the number of people who develop AMD will increase dramatically in the years ahead. Unless successful means of prevention or treatment are developed, blindness from AMD -- and its importance as a public health problem -- will increase.\n\n

\n\n\nFor more information, visit
\nAge-Related Eye Disease Study
\n\n\n\n"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/c30a5cac-2566-4726-bf2f-ef2e635696a1.jpg"}],"$L22","$L23"],"error":null,"digest":"$undefined"}